Get Live Data

Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share News
  5. UK BROKER RATINGS SUMMARY: Peel Hunt Initiates Whitbread With Buy

Pin to quick picksGlaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,653.00
Bid: 1,654.00
Ask: 1,654.50
Change: 12.50 (0.76%)
Spread: 0.50 (0.03%)
Open: 1,638.50
High: 1,655.50
Low: 1,634.00
Prev. Close: 1,640.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Peel Hunt Initiates Whitbread With Buy

Mon, 04th Nov 2019 09:10

(Alliance News) - The following London-listed shares received analyst recommendations on Monday morning and Friday afternoon:

----------

FTSE 100

----------

PEEL HUNT INITIATES WHITBREAD WITH 'BUY' - TARGET 4800 PENCE

----------

UBS CUTS SAGE GROUP PRICE TARGET TO 620 (625) PENCE - 'SELL'

----------

UBS RAISES STANDARD CHARTERED PRICE TARGET TO 690 (650) PENCE - 'NEUTRAL'

----------

UBS CUTS LLOYDS PRICE TARGET TO 62 (65) PENCE - 'BUY'

----------

JPMORGAN CUTS LLOYDS PRICE TARGET TO 68 (72) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS SMITH & NEPHEW PRICE TARGET TO 1711 (1814) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS EVRAZ PRICE TARGET TO 375 (400) PENCE - 'UNDERWEIGHT'

----------

LIBERUM RAISES GLAXOSMITHKLINE PRICE TARGET TO 1890 (1510) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS VODAFONE PRICE TARGET TO 240 (250) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS RSA INSURANCE PRICE TARGET TO 560 (565) PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES INTERNATIONAL CONSOLIDATED AIRLINES PRICE TARGET TO 670 (630) PENCE - 'BUY'

----------

GOLDMAN CUTS EXPERIAN PRICE TARGET TO 2500 (2600) PENCE - 'NEUTRAL'

----------

JEFFERIES CUTS IMPERIAL BRANDS PRICE TARGET TO 2400 (3800) PENCE - 'BUY'

----------

JEFFERIES CUTS BRITISH AMERICAN TOBACCO PRICE TARGET TO 4800 (4900) PENCE - 'BUY'

----------

CREDIT SUISSE CUTS RECKITT-BENCKISER-PRICE TARGET TO 5550 (5800) PENCE - UNDERPERFORM

----------

CREDIT SUISSE CUTS SMITH & NEPHEW PRICE TARGET TO 1725 (1770) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

LIBERUM RAISES PETS AT HOME TO 'BUY' ('HOLD')

----------

UBS CUTS ELEMENTIS PRICE TARGET TO 175 (185) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES CAPITA GROUP PRICE TARGET TO 140 (120) PENCE - 'HOLD'

----------

BARCLAYS RAISES WORKSPACE GROUP PRICE TARGET TO 1000 (980) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES DERWENT LONDON PRICE TARGET TO 3100 (3000) PENCE - 'UNDERWEIGHT'

----------

BARCLAYS CUTS BBA AVIATION PRICE TARGET TO 347 (350) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES FUTURE PRICE TARGET TO 1755 (1530) PENCE - 'BUY'

----------

BERENBERG CUTS MAN GROUP PRICE TARGET TO 192 (206) PENCE - 'BUY'

----------

BERENBERG CUTS BOVIS HOMES PRICE TARGET TO 1220 (1230) PENCE - 'BUY'

----------

JPMORGAN RAISES TRAVIS PERKINS PRICE TARGET TO 1400 (1356) PENCE - 'NEUTRAL'

----------

JEFFERIES CUTS WEIR GROUP PRICE TARGET TO 1395 (1440) PENCE - 'HOLD'

----------

OTHER MAIN MARKET AND AIM

----------

LIBERUM CUTS LOOKERS TO 'HOLD' ('BUY') - TARGET 30 (68) PENCE

----------

BERENBERG RAISES CHEMRING GROUP PRICE TARGET TO 200 (190) PENCE - 'HOLD

----------

BERENBERG RAISES TEAM17 PRICE TARGET TO 375 (330) PENCE - 'BUY'

----------

JPMORGAN CUTS FEVERTREE DRINKS PRICE TARGET TO 2400 (2740) PENCE - 'OVERWEIGHT'

----------

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Read more
4 Jan 2024 14:01

UK dividends calendar - next 7 days

Friday 5 January 
British Land Co PLCdividend payment date
Hill & Smith PLCdividend payment date
JD Sports Fashion PLCdividend payment date
JPMorgan Global Growth & Income PLCdividend payment date
Liontrust Asset Management PLCdividend payment date
Lok'n Store Group PLCdividend payment date
Real Estate Credit Investments Ltddividend payment date
RS Group PLCdividend payment date
Tate & Lyle PLCdividend payment date
Monday 8 January 
abrdn Equity Income Trust PLCdividend payment date
Intermediate Capital Group PLCdividend payment date
Tuesday 9 January 
no events scheduled 
Wednesday 10 January 
Assura PLCdividend payment date
Bellway PLCdividend payment date
Fidelity Special Values PLCdividend payment date
LXi REIT PLCdividend payment date
Severn Trent PLCdividend payment date
Volex PLCdividend payment date
Vp PLCdividend payment date
Thursday 11 January 
AJ Bell PLCex-dividend payment date
Ashtead Group PLCex-dividend payment date
BlackRock Latin American Investment Trust PLCex-dividend payment date
CMC Markets PLCdividend payment date
dotdigital Group PLCex-dividend payment date
Ecora Resources PLCex-dividend payment date
European Assets Trust PLCex-dividend payment date
Foresight Group Holdings Ltdex-dividend payment date
GSK PLCdividend payment date
ICG-Longbow Senior Secured UK Property Debt Investments Ltdex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
Keystone Positive Change Investment Trust PLCex-dividend payment date
LondonMetric Property PLCdividend payment date
Murray International Trust PLCex-dividend payment date
National Grid PLCdividend payment date
Primary Health Properties PLCex-dividend payment date
Sage Group PLCex-dividend payment date
Smiths News PLCex-dividend payment date
SSE PLCex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
TR Property Investment Trust PLCdividend payment date
Walker Crips Group PLCex-dividend payment date
WH Smith PLCex-dividend payment date
Worldwide Healthcare Trust PLCdividend payment date
XPS Pensions Group PLCex-dividend payment date
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
12345678910

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.